Streetbeat News

Products Services

HWH

HWH International Inc. (NASDAQ:HWH) has acquired a café in Seocho-gu, South Korea, launching its second Hapi Cafe outlet. This move aligns with HWH's vision of Health, Wealth, and Happiness, offering healthy food options, functional coffee, and a co-working space. The new café is in a prestigious French neighborhood, enhancing HWH's presence in the South Korean market. Chairman Chan Heng Fai emphasized the expansion's role in delivering value and experiences to members and the public.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:28 pm

JANX

Janux shares surged following the announcement of positive updated clinical data for its two clinical programs.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:28 pm

DOGEUSD

SHIBUSD

A crypto wallet turned $876 into $1.2 million in 91 days by trading tokens LILA, CRE, RSTK, GPU, and VRD, achieving a 57.4% win rate. The success story raises questions about fair play and insider information. Memecoins like DOGE and SHIB have not matched the growth of newer rivals but maintain higher market caps. Traders are cautioned about the risk of rug pulls with memecoins.

Portfolio Pulse from Khyathi Dalal

February 26, 2024 | 9:25 pm

ZM

Zoom Video Communications Inc (NASDAQ:ZM) reported Q4 earnings with a revenue increase of 2.6% year-over-year to $1.15 billion, surpassing the consensus estimate of $1.13 billion. Earnings per share were $1.42, beating estimates of $1.15. The company saw a 4.9% increase in enterprise revenue, while online revenue slightly declined by 0.5%. Zoom ended the quarter with 220,400 enterprise customers, a 3.5% increase from the previous year, and introduced Zoom AI Companion, a generative AI digital assistant. The company provided a mixed outlook for the next quarter and full year, slightly below some estimates, but announced a $1.5 billion stock repurchase program. After the announcement, Zoom shares surged 12.8% in after-hours trading.

Portfolio Pulse from Adam Eckert

February 26, 2024 | 9:22 pm

ETHUSD

Ethereum (ETH) surged to $3,200, marking its first reach to this level since April 2022, with a 3.6% increase on the day. The upcoming Dencun upgrade in March and the potential approval of an Ether spot ETF in May are key drivers of this rally. The upgrade aims to address scalability issues and improve network efficiency. Ethereum's bullish trend follows Bitcoin's, with expectations of surpassing $4,000 if the ETF is approved. Open Interest in Ethereum has hit a two-year high, indicating increased market speculation and investment. Major firms like BlackRock, VanEck, and Grayscale are awaiting regulatory approval for their Ether ETF applications, with Coinbase named as custodian for five of these applications. However, the market sees only a 44% chance of ETF approval by May 31.

Portfolio Pulse from Khyathi Dalal

February 26, 2024 | 9:19 pm

GILD

Gilead Sciences announced that the FDA has approved an expanded indication for Biktarvy, allowing it to treat people with HIV who have suppressed viral loads and pre-existing resistance. This approval broadens the potential patient base for Biktarvy, enhancing its marketability and utility in HIV treatment.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:15 pm

ACB

CRLBF

CURLF

GTBIF

HITI

TCNNF

TLRY

Following Germany's decision to legalize limited cannabis possession, U.S. and Canadian cannabis stocks like Curaleaf Holdings, Trulieve Cannabis Corp., Green Thumb Industries, Cresco Labs, Tilray, and Aurora Cannabis saw movements in their stock prices. Analysts predict significant growth potential in the German market, comparing it to Florida's medical cannabis market. Companies like Tilray and Aurora Cannabis, already established in Germany, are well-positioned to benefit. Curaleaf's affiliate owns a German importer, and High Tide Inc. expressed enthusiasm about entering the German market.

Portfolio Pulse from Maureen Meehan

February 26, 2024 | 9:13 pm

CDXS

Codexis, a leading enzyme engineering company, has entered into an exclusive licensing agreement with Roche, a global pioneer in pharmaceuticals and diagnostics, for the development of a novel double-stranded DNA ligase. This partnership aims to leverage Codexis' proprietary technology to enhance Roche's capabilities in diagnostics and pharmaceutical development.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:10 pm

STAA

STAAR Surgical Company projects its FY24 financial outlook with net sales expected to be between $335 million to $340 million, and an Adjusted EBITDA of approximately $36 million. Adjusted EBITDA per diluted share is anticipated to be around $0.70. The forecast includes a 7% growth in EVO ICL sales in the APAC region, with a 10% increase in China, a 10% growth in the Americas including the U.S., and EMEA sales remaining steady with the previous fiscal year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:03 pm

AMC

AMC Entertainment Holdings is anticipated to report its Q4 financial results, with analysts expecting a revenue of $1.046 billion and a loss of 57 cents per share. Despite a weaker blockbuster slate in 2023 compared to 2022, the inclusion of Taylor Swift and Beyonce concert films could positively impact ticket prices. Analysts highlight AMC's market share expansion, heavy debt load, and lack of dividend payout as key factors. The company's share price has significantly declined, trading closer to its historical multiple.

Portfolio Pulse from Chris Katje

February 26, 2024 | 9:01 pm